Newsroom

Washington, DC – Congresswoman Diana DeGette (D-CO), Chief Deputy Whip, and 53 House and Senate colleagues sent a bipartisan letter today to President Donald J. Trump requesting that he urge Attorney General Jeff Sessions to reinstate the Cole Memorandum. Doing so would create a pathway to a more comprehensive marijuana policy that respects state interests.

Washington, DC – Congresswoman Diana DeGette (D-CO), Chief Deputy Whip, said she would vote against the fourth consecutive stopgap spending bill for this fiscal year when it comes before the House of Representatives later today.

Washington, DC – After failing to provide a budget solution that addresses a wide array of critical priorities, Republicans have shut down the federal government. As Americans brace for the Trump Shutdown, Congresswoman Diana DeGette (D-CO), Chief Deputy Whip, strongly condemned Republican leaders for failing to meet the needs of the American people.

Washington, DC – Congresswoman Diana DeGette (D-CO), Chief Deputy Whip, said she would vote against the fourth consecutive stopgap spending bill for this fiscal year released by the Republican majority.

Denver – Congresswoman Diana DeGette has nominated 21 local students from her district to United States service academies.

Each year, the congresswoman has the honor of reviewing the applications of high school seniors who intend to attend the academies, and then nominating a select few of the applicants. A volunteer citizen advisory board helps select the strongest candidates.

Washington, DC – The top Justice Department official in Colorado has affirmed to the state's delegation to Congress that recently-issued federal guidelines regarding marijuana laws will not lead to an increase in marijuana prosecutions at the expense of other high-priority law enforcement issues.

Washington, DC – Congresswoman Diana DeGette's bill promoting energy conservation and encouraging innovations in LED lighting was signed into law today.

Washington, DC – In their continuing inquiry into skyrocketing costs for insulin, Diabetes Caucus co-chairs Rep. Diana DeGette (D-CO) and Rep. Tom Reed (R-NY) today sent five more letters to health care industry stakeholders seeking further information about health plan benefit design and drug discount programs offered by pharmaceutical companies.